Kestrel

LNWH - Point-Of-Care Testing for Genotype CYP2C19

London North West University Healthcare NHS Trust · published Wed 4 Nov 2026

In plain English

Reading the notice and writing a summary. This takes a few seconds the first time.

This tender's documents aren't on Find a Tender; the buyer's portal has them.

The notice as published

Provision of a point-of-care pharmacogenetic testing service for the rapid identification of CYP2C19 genetic variants associated with altered metabolism and response to clopidogrel.